IBDEI12D ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18960,0)
 ;;=295.90^^104^1106^13
 ;;^UTILITY(U,$J,358.3,18960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18960,1,2,0)
 ;;=2^295.90
 ;;^UTILITY(U,$J,358.3,18960,1,5,0)
 ;;=5^Schizophrenia NOS,Unspec
 ;;^UTILITY(U,$J,358.3,18960,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,18961,0)
 ;;=300.11^^104^1107^1
 ;;^UTILITY(U,$J,358.3,18961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18961,1,2,0)
 ;;=2^300.11
 ;;^UTILITY(U,$J,358.3,18961,1,5,0)
 ;;=5^Conversion Disorder
 ;;^UTILITY(U,$J,358.3,18961,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,18962,0)
 ;;=300.7^^104^1107^2
 ;;^UTILITY(U,$J,358.3,18962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18962,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,18962,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,18962,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,18963,0)
 ;;=300.81^^104^1107^3
 ;;^UTILITY(U,$J,358.3,18963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18963,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,18963,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,18963,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,18964,0)
 ;;=307.1^^104^1108^1
 ;;^UTILITY(U,$J,358.3,18964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18964,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,18964,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,18964,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,18965,0)
 ;;=307.51^^104^1108^2
 ;;^UTILITY(U,$J,358.3,18965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18965,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,18965,1,5,0)
 ;;=5^Bulemia
 ;;^UTILITY(U,$J,358.3,18965,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,18966,0)
 ;;=307.50^^104^1108^3
 ;;^UTILITY(U,$J,358.3,18966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18966,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,18966,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,18966,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,18967,0)
 ;;=333.99^^104^1109^1
 ;;^UTILITY(U,$J,358.3,18967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18967,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,18967,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,18967,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,18968,0)
 ;;=332.0^^104^1109^3
 ;;^UTILITY(U,$J,358.3,18968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18968,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,18968,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,18968,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,18969,0)
 ;;=333.79^^104^1109^2
 ;;^UTILITY(U,$J,358.3,18969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18969,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,18969,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,18969,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,18970,0)
 ;;=333.85^^104^1109^4
 ;;^UTILITY(U,$J,358.3,18970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18970,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,18970,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,18970,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,18971,0)
 ;;=V87.39^^104^1110^1
 ;;^UTILITY(U,$J,358.3,18971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18971,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,18971,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,18971,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,18972,0)
 ;;=310.0^^104^1111^2
 ;;^UTILITY(U,$J,358.3,18972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18972,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,18972,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,18972,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,18973,0)
 ;;=310.1^^104^1111^3
 ;;^UTILITY(U,$J,358.3,18973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18973,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,18973,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
